Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer

By sjmartinez • July 14, 2024

Preston MA, Ebrahimi R, Hong A, Bobbili P, Desai R, Duh MS, Gandhi R, Hanson S, Dufour R, Morgans AK. Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer. Urol Oncol. 2024 Jul 12:S1078-1439(24)00499-X. doi: 10.1016/j.urolonc.2024.05.026. Epub ahead of print. PMID: 39003108.

Tags: Androgen deprivation therapy, Cardiology/Epi, cardiovascular risk, Continuous ADT, Endocrine or metabolic risk, Intermittent ADT, Nonmetastatic prostate cancer, Publications, Veterans Administration

Cross-pollination of two specialties: potential repurposing of cancer and cardiovascular drugs for the benefit of the other

Leiva O, DeCara JM, Yang EH, Gozdecki L, Kanelidis A, Swat S. Cross-pollination of two specialties: potential repurposing of cancer and cardiovascular drugs for the[...]

Primary Central Nervous System (CNS) Post-Transplant Lymphoproliferative Disorder: A Case Report

Taitt JM, Lees C, Tran GN, Patel S. Primary Central Nervous System (CNS) Post-Transplant Lymphoproliferative Disorder: A Case Report. Cureus. 2025 Oct 21;17(10):e95108. doi: 10.7759/cureus.95108.[...]

Trends and disparities in mortality associated with peripheral artery disease and hyperlipidemia, 1999-2024

Khan S, Hassan M, Hussain M, Dhedhi HAA, Fatima W, Nawaz J, Ahsan A, Pirih FNU, Khalid N, Qaisar M, Qureshi AA, Baig M, Eltawansy[...]